HealthEquity Profit Margin 2014-2025 | HQY

Current and historical gross margin, operating margin and net profit margin for HealthEquity (HQY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. HealthEquity net profit margin as of January 31, 2025 is 8.06%.
HealthEquity Annual Profit Margins
HealthEquity Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Services $8.752B $1.200B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.538B 26.55
Elevance Health (ELV) United States $93.196B 12.03
CVS Health (CVS) United States $80.632B 10.02
Cencora (COR) United States $56.777B 19.75
DiDi Global (DIDIY) China $22.309B 33.86
Natera (NTRA) United States $21.101B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.924B 13.68
EUROFINS SCIENT (ERFSF) Luxembourg $12.447B 0.00
CochLear (CHEOY) Australia $11.597B 0.00
Revvity (RVTY) United States $11.030B 18.98
ICON (ICLR) Ireland $10.666B 9.92
Viatris (VTRS) United States $10.422B 3.58
Doximity (DOCS) United States $9.895B 46.09
Avantor (AVTR) United States $9.179B 13.34
Medpace Holdings (MEDP) United States $8.813B 23.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
Charles River Laboratories (CRL) United States $7.050B 13.81
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $4.153B 24.48
BrightSpring Health Services (BTSG) United States $4.151B 38.42
Sotera Health (SHC) United States $3.639B 20.68
Alignment Healthcare (ALHC) United States $3.102B 0.00
Surgery Partners (SGRY) United States $2.973B 38.67
Concentras Parent (CON) United States $2.889B 16.70
Organon (OGN) United States $2.277B 2.42
Ardent Health Partners (ARDT) United States $2.164B 9.23
GeneDx Holdings (WGS) United States $2.058B 79.24
Premier (PINC) United States $1.902B 14.44
Progyny (PGNY) United States $1.875B 41.26
PACS (PACS) United States $1.606B 0.00
GoodRx Holdings (GDRX) United States $1.418B 28.36
Pediatrix Medical (MD) United States $1.302B 9.91
Teladoc Health (TDOC) United States $1.288B 0.00
Establishment Labs Holdings (ESTA) $1.089B 0.00
Agilon Health (AGL) United States $1.027B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.988B 15.43
Nutex Health (NUTX) United States $0.986B 14.90
AMN Healthcare Services Inc (AMN) United States $0.878B 8.22
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.718B 4.84
InnovAge Holding (INNV) United States $0.572B 0.00
Enhabit (EHAB) United States $0.537B 44.21
Auna S.A (AUNA) Luxembourg $0.518B 11.67
LifeMD (LFMD) United States $0.484B 0.00
Sonida Senior Living (SNDA) United States $0.484B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.429B 0.00
SBC Medicals (SBC) United States $0.368B 0.00
Beauty Health (SKIN) United States $0.212B 0.00
Oncology Institute (TOI) United States $0.210B 0.00
Performant Healthcare (PHLT) United States $0.210B 0.00
DocGo (DCGO) United States $0.142B 23.17
KindlyMD (KDLY) United States $0.092B 0.00
So-Young (SY) China $0.087B 0.00
OncoCyte (OCX) United States $0.084B 0.00
Sera Prognostics (SERA) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.067B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.040B 0.00
Basel Medical Group (BMGL) Singapore $0.037B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
ModivCare (MODV) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00